Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Mouth Neoplasms 1

Interventions

Cisplatin 98pembrolizumab 79Radiotherapy 49Carboplatin 41Magnetic Resonance Spectroscopy 37toripalimab 34Radiotherapy, Intensity-Modulated 34Gemcitabine 29Docetaxel 28Cetuximab 28Specimen Handling 26Surgical Procedures, Operative 23Paclitaxel 23Fluorouracil 22Radiation 20Nivolumab 20Biopsy 18Drug Therapy 17Chemoradiotherapy 17Blood Specimen Collection 17Capecitabine 15Surveys and Questionnaires 14Standard of Care 14tislelizumab 13Platinum 13camrelizumab 12nimotuzumab 11Immune Checkpoint Inhibitors 11130-nm albumin-bound paclitaxel 111,2-diaminocyclohexaneplatinum II citrate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Nalbuphine × Head & Neck × Clear all
NCT07401641 2026-02-10

Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
60 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡